CME professionals' reactions to the Senate Finance Committee report on medical education run the gamut, from those who agree that pharmaceutical company funding results in biased programming to those who think the committee is wasting its time and should focus on other issues, such as Medicare fraud. Regardless of their opinions, many agree that the result will be stricter guidelines from the ACCME.
Register to view the full article
Register for MeetingsNet.com and gain access to premium content including the CMI 25 Listing, our monthly digital edition, the MeetingsNet app, live and on-demand webinars, and much more.
0 comments
Hide comments